Glycogen synthase kinase 3: A key regulator of cellular fate

被引：328

作者：

Forde, J. E. ^{[1
]}

Dale, T. C. ^{[1
]}

机构：

[1] Cardiff Sch Biosci, Cardiff CF10 3US, Wales

来源：

CELLULAR AND MOLECULAR LIFE SCIENCES | 2007年 / 64卷 / 15期

基金：

英国生物技术与生命科学研究理事会;

关键词：

glycogen synthase kinase-3 (GSK-3); mechanism of action; inhibitors; signalling; disease; kinase; regulation;

D O I：

10.1007/s00018-007-7045-7

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The serine/threonine kinase glycogen synthase kinase-3 (GSK-3) was initially identified as a key regulator of insulin-dependent glycogen synthesis. GSK-3 was subsequently shown to function in a wide range of cellular processes including differentiation, growth, motility and apoptosis. Aberrant regulation of GSK-3 has been implicated in a range of human pathologies including Alzheimer's disease, non-insulin dependent diabetes mellitus ( NIDDM) and cancer. As a consequence, the regulation of GSK-3 and the therapeutic potential of GSK-3 inhibitors have become key areas of investigation. This review will focus on the mechanisms of GSK-3 regulation, with emphasis on modulation by upstream signals, control of substrate specificity and GSK-3 localisation. The details of these mechanisms will be discussed in the context of specific signalling pathways.

引用

收藏

页码：1930 / 1944

页数：15

相关论文

共 139 条

[1] Glycogen synthase kinase-3: Properties, functions, and regulation [J].

Ali, A ;

Hoeflich, KP ;

Woodgett, JR .

CHEMICAL REVIEWS, 2001, 101 (08) :2527-2540

[2] Axin-mediated CKI phosphorylation of β-catenin at Ser 45:: a molecular switch for the Wnt pathway [J].

Amit, S ;

Hatzubai, A ;

Birman, Y ;

Andersen, JS ;

Ben-Shushan, E ;

Mann, M ;

Ben-Neriah, Y ;

Alkalay, I .

GENES & DEVELOPMENT, 2002, 16 (09) :1066-1076

[3] Yeast glycogen synthase kinase 3 is involved in protein degradation in cooperation with Bul1, Bul2, and Rsp5 [J].

Andoh, T ;

Hirata, Y ;

Kikuchi, A .

MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (18) :6712-6720

[4] Proteolysis that is inhibited by Hedgehog targets Cubitus interruptus protein to the nucleus and converts it to a repressor [J].

AzaBlanc, P ;

RamirezWeber, FA ;

Laget, MP ;

Schwartz, C ;

Kornberg, TB .

CELL, 1997, 89 (07) :1043-1053

[5] The structure of phosphorylated GSK-3β complexed with a peptide, FRATtide, that inhibits β-catenin phosphorylation [J].

Bax, B ;

Carter, PS ;

Lewis, C ;

Guy, AR ;

Bridges, A ;

Tanner, R ;

Pettman, G ;

Mannix, C ;

Culbert, AA ;

Brown, MJB ;

Smith, DG ;

Reith, AD .

STRUCTURE, 2001, 9 (12) :1143-1152

[6] Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3 [J].

Beals, CR ;

Sheridan, CM ;

Turck, CW ;

Gardner, P ;

Crabtree, GR .

SCIENCE, 1997, 275 (5308) :1930-1933

[7] EMBRYONIC LETHALITY AND LIVER DEGENERATION IN MICE LACKING THE RELA COMPONENT OF NF-KAPPA-B [J].

BEG, AA ;

SHA, WC ;

BRONSON, RT ;

GHOSH, S ;

BALTIMORE, D .

NATURE, 1995, 376 (6536) :167-170

[8] Glycogen synthase kinase 3: a drug target for CNS therapies [J].

Bhat, RV ;

Haeberlein, SLB ;

Avila, J .

JOURNAL OF NEUROCHEMISTRY, 2004, 89 (06) :1313-1317

[9] Glycogen synthase kinase-3β facilitates staurosporine- and heat shock-induced apoptosis -: Protection by lithium [J].

Bijur, GN ;

De Sarno, P ;

Jope, RS .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (11) :7583-7590

[10] ACTIVATION OF PROTEIN-KINASE-C DECREASES PHOSPHORYLATION OF C-JUN AT SITES THAT NEGATIVELY REGULATE ITS DNA-BINDING ACTIVITY [J].

BOYLE, WJ ;

SMEAL, T ;

DEFIZE, LHK ;

ANGEL, P ;

WOODGETT, JR ;

KARIN, M ;

HUNTER, T .

CELL, 1991, 64 (03) :573-584

← 1 2 3 4 5 6 7 8 9 10 →